Skip to main content

Table 1 Association of sex and allele frequency of the rs2232365 polymorphism in patients with chronic diseases, stratified according to the clinical-pathological profile

From: Sex and FOXP3 gene rs2232365 polymorphism may be associated with the clinical and pathological aspects of chronic viral diseases

 

Sex

Alleles (rs2232365)

Female (%)

Alleles (rs2232365)

Male (%)

Multiple logistic regression

Female (323)

Male (373)

Statistica

T

C

Statistica

T

C

Statistica

Group

   

349 (54.03)

297 (45.98)

188 (50.40)

185 (49.60)

 

 CVLD

39 (12.07)

62 (16.62)

0.07

39 (50.00)

39 (50.00)

0.47

31 (50.00)

31 (50.00)

0.55

NS

 HTLV-1

44 (13.62)

23 (06.16)

0.03 1.91 (1.10–3.33)

52 (59.09)

36 (40.91)

0.62

7 (33.33)

16 (66.67)

0.05 0.36 (0.14–0.92)

Sex*:

2.11 (1.18–3.75)

T*:

0.43 (0.20–0.95)

 CAD

91 (28.17)

139 (37.27)

0.02 1.53 (1.08–2.16)

93 (51.10)

89 (48.90)

0.41

68 (48.92)

71 (51.08)

0.35

Sex*:

1.44 (0.95–2.19)

 CG

149 (46.13)

149 (39.95)

 

165 (55.40)

133 (44.63)

 

82 (54.31)

67 (45.70)

  

Inflammation (CVLD)

 A0-A1

24 (61.54)

43 (69.35)

0.52

24 (50.00)

24 (50.00)

1.0

20 (57.90)

23 (53.49)

0.58

 

 A2-A3

15 (38.46)

19 (30.65)

 

15 (50.00)

15 (50.00)

 

11 (46.51)

8 (42.11)

  

Fibrosis (CVLD)

 F0-F1

20 (51.28)

29 (46.77)

0.82

20 (50.00)

20 (50.00)

1.0

10 (34.48)

19 (65.52)

0.05 4.18 (1.13–15.4)

T*:

1.11 (0.43–2.90)

 F2

8 (20.51)

17 (27.42)

 

8 (50.00)

8 (50.00)

 

10 (58.82)

7 (41.18)

  

 F3-F4

11 (28.21)

16 (25.81)

 

11 (50.00)

11 (50.00)

 

11 (68.75)

5 (31.25)

  

HTLV-1

 Asymptomatic

27 (61.36)

13 (61.90)

1.0

32 (59.26)

22 (40.74)

0.86

4 (30.77)

9 (69.23)

0.87

 

 HAM/TSP

17 (38.64)

8 (38.10)

 

20 (58.82)

14 (41.18)

 

3 (37.50)

5 (62.50)

  

Risky infections (CAD)

Chlamydia+

78 (85.71)

121 (87.05)

0.84

80 (86.02)

74 (85.06)

1.0

60 (88.24)

61 (85.92)

0.80

 

Chlamydia-

13 (14.29)

18 (12.95)

 

13 (13.98)

13 (14.94)

 

8 (11.76)

10 (14.08)

  

Species of Chlamydia

C. pneumoniae

55 (70.51)

82 (67.77)

0.74

58 (70.73)

56 (66.67)

0.99

43 (71.67)

39 (63.93)

0.50

 

C. trachomatis

3 (03.85)

3 (02.48)

 

2 (02.44)

2 (02.38)

 

2 (03.33)

1 (01.64)

  

Coinfection

20 (25.64)

36 (29.75)

 

22 (26.83)

20 (23.81)

 

15 (25.00)

21 (34.43)

  
  1. CVLD Chronic Viral Liver Diseases
  2. CAD Coronary Artery Disease
  3. CG Control Group
  4. ax2 test. Odds ratio (Confidence interval - 95%)
  5. *0.05 ≥ p ≥ 0.01
  6. **0.01 ≥ p ≥ 0.001